— Know what they know.
Not Investment Advice

TXG NASDAQ

10x Genomics, Inc.
1W: +4.4% 1M: -14.9% 3M: +55.1% YTD: +339.0% 1Y: +446.1% 3Y: +83.6% 5Y: -52.6%
$78.02
+5.06 (+6.94%)
After Hours: $78.75 (+0.73, +0.94%)
Weekly Expected Move ±12.6%
$53 $62 $71 $80 $89
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $9.5B mcap · 116M float · 2.89% daily turnover · Short 55% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 0.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.03 (down more than 99.9%), 10x Genomics, Inc. would be worth roughly what it owes.
Total debt $78.8M against a stock market value of $9.51B.
Distance to default 8.82 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $12.0M (short-term plus half of long-term), stock volatility 73.2%; Altman Z'' 2.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.2 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -19.8%  ·  5Y Avg: -49.7%
Cost Advantage ★
54
Intangibles
44
Switching Cost
52
Network Effect
47
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TXG shows a Weak competitive edge (45.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -19.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$40
Low
$74
Avg Target
$110
High
Based on 14 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 11Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$73.57
Analysts14
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-13 Stifel Nicolaus — $50 $70 +20 -3.7% $72.68
2026-10-12 Morgan Stanley — $40 $70 +30 -11.3% $78.95
2026-10-12 Canaccord Genuity Kyle Mikson $60 $100 +40 +24.0% $80.65
2026-10-07 Barclays — $40 $110 +70 +36.4% $80.66
2026-09-29 Leerink Partners — $40 $90 +50 +1.8% $88.42
2026-09-28 Argus Research — Initiated $110 — +28.3% $85.71
2026-09-28 Piper Sandler — $47 $80 +33 -6.7% $85.71
2026-09-09 UBS Doug Schenkel $20 $68 +48 +3.7% $65.60
2026-09-01 RBC Capital Dan Leonard Initiated $70 — +12.1% $62.45
2026-08-12 Stephens Mason Carrico Initiated $65 — +11.4% $58.34
2026-08-10 Piper Sandler — Initiated $47 — -9.7% $52.03
2026-08-10 Canaccord Genuity Kyle Mikson $50 $60 +10 +15.3% $52.03
2026-08-07 Morgan Stanley — $37 $40 +3 -17.2% $48.31
2026-08-07 Stifel Nicolaus — $25 $50 +25 +6.0% $47.15
2026-07-17 Leerink Partners — Initiated $40 — -9.3% $44.12
2026-07-14 Canaccord Genuity Kyle Mikson $22 $50 +28 +19.7% $41.77
2026-07-09 Morgan Stanley Kallum Titchmarsh $22 $37 +15 -1.3% $37.47
2026-06-24 Barclays Luke Sergott $30 $40 +10 +25.5% $31.87
2026-05-12 Morgan Stanley — $20 $22 +2 +6.8% $20.60
2026-04-14 Barclays — $22 $30 +8 +27.2% $23.58
2026-03-02 Stifel Nicolaus Daniel Arias $20 $25 +5 +11.7% $22.38
2026-02-20 UBS — $13 $20 +7 +4.2% $19.19
2026-02-13 Deutsche Bank — $14 $17 +3 -12.4% $19.40
2026-02-13 Stifel Nicolaus — Initiated $20 — +14.2% $17.51
2026-02-13 Canaccord Genuity Kyle Mikson $20 $22 +2 +25.6% $17.51
2026-01-12 Needham — Initiated $21 — +2.6% $20.46
2025-12-22 Canaccord Genuity — $16 $20 +4 +24.6% $16.05
2025-12-15 Barclays — $24 $22 -2 +42.4% $15.45
2025-12-01 Morgan Stanley Kallum Titchmarsh $46 $20 -26 +10.6% $18.08
2025-08-11 Canaccord Genuity Kyle Mikson $32 $16 -16 +29.1% $12.39
2025-08-08 UBS Dan Leonard Initiated $13 — +8.1% $12.03
2025-08-08 Deutsche Bank Justin Bowers $25 $14 -11 +13.9% $12.29
2024-08-13 Morgan Stanley Tejas Savant Initiated $46 — +134.1% $19.65
2024-07-23 Canaccord Genuity Kyle Mikson Initiated $32 — +76.7% $18.11
2024-07-10 Deutsche Bank Justin Bowers $50 $25 -25 +37.0% $18.25
2024-06-28 Barclays Luke Sergott $36 $24 -12 +20.9% $19.85
2024-06-02 Jefferies Tycho Peterson Initiated $24 — +7.0% $22.42
2024-05-01 Barclays Luke Sergott $45 $36 -9 +23.0% $29.28
2024-04-10 Barclays Luke Sergott Initiated $45 — +20.4% $37.37
2022-12-14 Deutsche Bank — Initiated $50 — +42.0% $35.21

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TXG receives an overall rating of C. Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-12 C- C
2026-10-01 C C-
2026-06-03 C+ C
2026-05-11 C C+
2026-04-01 C+ C
2026-02-24 C C+
2026-02-18 C- C
2026-02-13 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 53 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
34
Growth
54
Value
33
Momentum
54
Safety
100
Cash Flow
77
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TXG scores highest in Safety (100/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
13.74
Safe Zone
Piotroski F-Score
5/9
✗ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.96
Unlikely Manipulator
Ohlson O-Score
-10.04
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 69.8/100
Trend: Improving
Earnings Quality
—
OCF/NI: -1.69x
Accruals: -20.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TXG scores 13.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TXG scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TXG's score of -2.96 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TXG's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TXG receives an estimated rating of A- (score: 69.8/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-132.51x
PEG
0.29x
P/S
16.51x
P/B
12.31x
P/FCF
41.04x
P/OCF
39.21x
EV/EBITDA
119.74x
EV/Revenue
7.31x
EV/EBIT
-546.25x
EV/FCF
37.14x
Earnings Yield
-1.51%
FCF Yield
2.44%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TXG currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.003
NI / EBT
×
Interest Burden
9.070
EBT / EBIT
×
EBIT Margin
-0.013
EBIT / Rev
×
Asset Turnover
0.614
Rev / Assets
×
Equity Multiplier
1.257
Assets / Equity
=
ROE
-9.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TXG's ROE of -9.4% is driven by Asset Turnover (0.614), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1791 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$78.02
Median 1Y
$65.74
5th Pctile
$23.96
95th Pctile
$179.78
Ann. Volatility
67.6%
Analyst Target
$73.57
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Serge Saxonov
Chief Executive Officer
$674,250 $5,020,269 $6,329,244
Eric S. Whitaker
Former Chief Legal Officer
$518,654 $2,629,967 $3,441,571
Benjamin J. Hindson
President and Chief Scientific Officer
$518,654 $1,793,155 $2,604,759
Adam S. Taich
Chief Financial Officer
$507,461 $1,441,065 $2,233,107

CEO Pay Ratio

24:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,329,244
Avg Employee Cost (SGA/emp): $268,365
Employees: 1,178

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
1,178
-9.8% YoY
Revenue / Employee
$545,690
Rev: $642,823,000
Profit / Employee
$-36,964
NI: $-43,544,000
SGA / Employee
$268,365
Avg labor cost proxy
R&D / Employee
$202,574
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -56.0% -7.5% -11.4% -18.2% -21.2% -20.5% -21.7% -21.9% -29.4% -33.0% -34.7% -31.6% -24.9% -25.2% -22.0% -11.3% -10.1% -5.8% -3.0% -9.4% -9.40%
ROA -44.8% -6.0% -9.1% -14.4% -16.8% -16.2% -17.3% -17.3% -23.0% -25.6% -27.3% -25.0% -19.4% -19.4% -17.2% -8.9% -7.8% -4.4% -2.4% -7.5% -7.47%
ROIC -1.3% -13.2% -18.0% -28.2% -30.2% -28.2% -29.0% -28.1% -37.9% -46.8% -49.4% -46.2% -38.5% -38.5% -37.8% -19.2% -15.5% -11.2% -8.6% -19.8% -19.82%
ROCE -50.0% -5.8% -9.2% -15.6% -18.5% -18.0% -18.8% -18.7% -25.9% -29.7% -31.6% -28.5% -21.5% -22.2% -19.3% -9.1% -8.3% 3.0% 5.3% -0.9% -0.91%
Gross Margin 80.4% 80.8% 77.7% 75.8% 76.8% 76.4% 73.3% 67.8% 62.2% 62.9% 65.9% 68.1% 70.2% 67.2% 68.1% 72.3% 67.3% 68.1% 70.4% 74.5% 74.48%
Operating Margin -12.7% -11.0% -36.5% -55.1% -30.5% -14.8% -38.7% -43.2% -61.7% -30.0% -43.6% -27.3% -27.4% -30.2% -25.4% 17.4% -21.6% -11.8% -11.3% -12.9% -12.95%
Net Margin -13.7% -12.9% -37.0% -56.2% -32.0% -11.0% -37.8% -42.5% -60.5% -26.6% -42.5% -24.8% -23.6% -29.7% -22.2% 20.0% -18.4% -9.8% -8.9% -11.9% -11.87%
EBITDA Margin -7.3% -5.9% -29.3% -48.2% -24.3% -5.0% -30.5% -33.3% -52.3% -19.0% -32.8% -17.1% -15.6% -22.9% -15.3% 27.0% -10.7% 38.3% -0.6% -5.9% -5.95%
FCF Margin -55.2% -25.0% -25.8% -32.4% -32.0% -32.0% -23.3% -20.7% -19.0% -10.3% -11.8% -5.3% 4.0% -1.1% 7.1% 8.8% 12.7% 20.2% 19.1% 19.7% 19.68%
OCF Margin -34.3% -4.4% -7.6% -11.7% -8.2% -6.5% -3.2% -2.0% -4.6% -2.5% -4.3% -1.2% 6.2% 1.1% 9.1% 10.4% 13.8% 21.2% 20.0% 20.6% 20.60%
ROE 3Y Avg snapshot only -17.72%
ROE 5Y Avg snapshot only -18.61%
ROA 3Y Avg snapshot only -13.91%
ROIC 3Y Avg snapshot only -39.84%
ROIC Economic snapshot only -7.83%
Cash ROA snapshot only 12.34%
Cash ROIC snapshot only 36.07%
CROIC snapshot only 34.47%
NOPAT Margin snapshot only -11.32%
Pretax Margin snapshot only -12.14%
R&D / Revenue snapshot only 36.76%
SGA / Revenue snapshot only 48.14%
SBC / Revenue snapshot only 16.01%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -35.45 -286.28 -96.46 -36.07 -19.43 -25.19 -37.00 -37.83 -21.74 -26.01 -16.95 -9.74 -14.93 -9.56 -6.82 -17.04 -19.22 -47.60 -120.22 -66.34 -132.508
P/S Ratio 35.15 33.98 17.22 10.32 6.45 8.10 12.03 11.47 8.22 10.72 7.16 3.70 4.33 2.86 1.71 2.24 2.29 3.22 4.26 8.08 16.512
P/B Ratio 20.17 20.39 10.65 6.56 4.19 5.19 8.04 8.21 6.52 8.95 6.23 3.23 3.77 2.46 1.51 1.86 1.87 2.60 3.34 6.04 12.310
P/FCF -63.73 -135.90 -66.80 -31.85 -20.18 -25.30 -51.60 -55.36 -43.24 -103.67 -60.59 -69.82 108.86 -259.49 24.13 25.35 17.97 15.93 22.29 41.04 41.039
P/OCF — — — — — — — — — — — — 69.60 262.02 18.86 21.54 16.57 15.23 21.31 39.21 39.215
EV/EBITDA -37.28 -657.15 -151.70 -44.50 -22.41 -29.94 -45.13 -48.06 -25.82 -30.92 -19.97 -10.89 -18.42 -10.71 -6.50 -28.05 -37.28 24.20 24.28 119.74 119.740
EV/Revenue 34.02 32.95 16.34 9.52 5.74 7.45 11.44 10.95 7.78 10.25 6.72 3.24 3.83 2.35 1.16 1.68 1.79 2.66 3.55 7.31 7.311
EV/EBIT -35.07 -305.83 -97.64 -34.46 -17.98 -23.82 -36.18 -37.37 -21.05 -25.50 -16.35 -8.77 -13.72 -8.08 -4.72 -13.63 -15.71 63.86 47.80 -546.25 -546.246
EV/FCF -61.67 -131.78 -63.39 -29.36 -17.97 -23.28 -49.07 -52.88 -40.94 -99.09 -56.81 -61.13 96.39 -213.31 16.31 19.01 14.07 13.12 18.54 37.14 37.142
Earnings Yield -2.8% -0.3% -1.0% -2.8% -5.1% -4.0% -2.7% -2.6% -4.6% -3.8% -5.9% -10.3% -6.7% -10.5% -14.7% -5.9% -5.2% -2.1% -0.8% -1.5% -1.51%
FCF Yield -1.6% -0.7% -1.5% -3.1% -5.0% -4.0% -1.9% -1.8% -2.3% -1.0% -1.7% -1.4% 0.9% -0.4% 4.1% 3.9% 5.6% 6.3% 4.5% 2.4% 2.44%
PEG Ratio snapshot only 0.290
Price/Tangible Book snapshot only 6.579
EV/OCF snapshot only 35.491
EV/Gross Profit snapshot only 10.440
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.41 6.77 7.38 5.65 4.96 4.85 5.37 5.94 5.37 4.69 5.22 5.22 4.90 4.97 5.37 5.84 4.48 4.46 5.90 5.69 5.693
Quick Ratio 6.90 6.23 6.71 5.05 4.34 4.23 4.64 5.09 4.60 4.11 4.45 4.42 4.12 4.26 4.68 5.23 4.06 4.09 5.42 5.25 5.249
Debt/Equity 0.10 0.10 0.13 0.13 0.12 0.12 0.13 0.13 0.13 0.13 0.13 0.12 0.12 0.12 0.11 0.11 0.21 0.20 0.10 0.10 0.095
Net Debt/Equity -0.65 -0.62 -0.54 -0.51 -0.46 -0.42 -0.39 -0.37 -0.35 -0.40 -0.39 -0.40 -0.43 -0.44 -0.49 -0.47 -0.41 -0.46 -0.56 -0.57 -0.573
Debt/Assets 0.08 0.08 0.10 0.10 0.10 0.09 0.10 0.10 0.10 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.16 0.15 0.08 0.08 0.076
Debt/EBITDA -0.19 -3.33 -1.88 -0.93 -0.75 -0.74 -0.75 -0.77 -0.55 -0.46 -0.44 -0.48 -0.66 -0.62 -0.72 -2.25 -5.30 2.24 0.87 2.09 2.092
Net Debt/EBITDA 1.24 20.55 8.15 3.76 2.76 2.61 2.33 2.25 1.45 1.43 1.33 1.55 2.38 2.32 3.11 9.35 10.34 -5.18 -4.91 -12.56 -12.563
Interest Coverage -461.05 -61.03 -108.05 -204.30 -283.42 -339.28 -462.03 -633.48 -1456.17 -7537.27 -17126.47 -21201.18 -14658.83 -44424.00 -51133.33 -15864.40 -12181.33 4454.83 7898.00 -2752.33 -2752.333
Equity Multiplier 1.24 1.25 1.24 1.28 1.28 1.28 1.26 1.25 1.27 1.30 1.28 1.28 1.30 1.29 1.28 1.27 1.31 1.31 1.25 1.25 1.248
Cash Ratio snapshot only 4.658
Debt Service Coverage snapshot only 12556.000
Cash to Debt snapshot only 7.006
FCF to Debt snapshot only 1.541
Defensive Interval snapshot only 422.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.45 0.50 0.51 0.50 0.51 0.50 0.53 0.57 0.61 0.62 0.65 0.66 0.67 0.65 0.68 0.67 0.65 0.66 0.67 0.61 0.614
Inventory Turnover 1.71 1.65 1.61 1.84 1.71 1.70 1.79 1.95 2.23 2.70 2.68 2.60 2.41 2.50 2.50 2.50 2.56 2.85 3.03 3.04 3.041
Receivables Turnover 8.02 7.19 7.45 7.33 6.22 5.45 6.94 6.94 6.31 5.65 7.39 7.06 6.72 6.03 8.68 9.13 10.08 9.53 11.75 12.65 12.652
Payables Turnover 4.93 6.72 4.78 4.91 5.75 6.18 5.42 6.03 8.81 11.22 8.95 10.06 9.34 13.70 13.05 10.57 9.03 15.52 14.12 10.09 10.094
DSO 45 51 49 50 59 67 53 53 58 65 49 52 54 61 42 40 36 38 31 29 28.8 days
DIO 213 222 226 199 213 215 204 187 164 135 136 141 152 146 146 146 142 128 120 120 120.0 days
DPO 74 54 76 74 63 59 67 61 41 33 41 36 39 27 28 35 40 24 26 36 36.2 days
Cash Conversion Cycle 184 218 199 174 208 223 189 179 180 167 145 156 167 180 160 151 138 143 126 113 112.7 days
Fixed Asset Turnover snapshot only 2.268
Operating Cycle snapshot only 148.9 days
Cash Velocity snapshot only 1.118
Capital Intensity snapshot only 1.670
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 75.3% 64.1% 50.0% 22.7% 9.7% 5.3% 7.4% 14.2% 17.3% 19.8% 16.6% 11.1% 6.6% -1.3% -0.1% 2.0% 1.9% 5.2% 2.3% -4.3% -4.28%
Net Income -2.4% 89.3% 83.3% 71.7% 63.3% -1.9% -95.7% -20.9% -33.6% -53.7% -51.6% -39.2% 18.3% 28.4% 40.6% 64.7% 58.2% 76.2% 85.6% 11.2% 11.20%
EPS -2.1% 89.7% 83.9% 72.7% 64.3% -1.8% -91.2% -17.7% -29.5% -48.7% -46.8% -35.3% 20.3% 30.2% 42.1% 66.0% 59.8% 77.2% 86.2% 14.9% 14.94%
FCF -1.4% 52.1% 55.4% 38.8% 36.4% -34.7% 2.8% 27.1% 30.3% 61.3% 40.8% 71.6% 1.2% 89.5% 1.6% 2.7% 2.3% 20.3% 1.8% 1.1% 1.14%
EBITDA -2.7% 95.2% 89.3% 77.3% 69.2% -4.2% -1.5% -21.6% -37.9% -59.6% -54.8% -44.9% 26.4% 34.7% 47.1% 79.5% 76.5% 1.5% 1.8% 2.0% 1.98%
Op. Income -2.4% 90.2% 84.0% 72.4% 64.0% -2.2% -1.1% -30.7% -45.2% -58.0% -54.2% -41.9% 14.3% 26.7% 37.3% 60.3% 54.3% 68.7% 77.5% 12.1% 12.08%
OCF Growth snapshot only 89.82%
Asset Growth snapshot only 5.11%
Equity Growth snapshot only 6.76%
Debt Growth snapshot only -9.16%
Shares Change snapshot only 4.40%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — 1.0% 55.8% 37.0% 31.3% 31.2% 27.5% 23.4% 15.9% 11.1% 7.6% 7.8% 9.0% 8.4% 7.6% 6.0% 2.8% 2.77%
Revenue 5Y — — — — — — — — — — — — 59.4% 34.9% 24.6% 20.7% 19.6% 16.6% 13.9% 8.7% 8.74%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — 1.0% 55.9% 36.0% 29.2% 26.1% 19.4% 14.0% 5.2% 2.1% -0.2% 0.8% 4.5% 4.0% 3.9% 3.1% 1.1% 1.10%
Gross Profit 5Y — — — — — — — — — — — — 55.8% 31.7% 21.5% 18.2% 16.5% 13.1% 10.3% 4.3% 4.28%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — 96.8% — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — 21.9% -20.7% 24.9% — — — — — —
Assets 3Y — — — — 20.3% 19.3% 18.4% 19.3% -3.1% 1.3% -1.1% -1.7% -1.8% -3.4% -3.4% -0.7% 1.0% 0.4% 0.1% 1.3% 1.34%
Assets 5Y — — — — — — — — — — — — 10.4% 8.7% 8.2% 11.0% -0.3% 2.3% 1.3% 1.1% 1.05%
Equity 3Y — — — — 22.6% 24.2% 25.2% 26.6% -3.3% 0.1% -1.5% -2.6% -3.3% -4.6% -4.3% -0.4% 0.4% -0.4% 0.5% 1.3% 1.34%
Book Value 3Y — — — — -22.2% 17.1% 18.0% 19.8% -8.0% -3.2% -4.5% -5.5% -6.0% -7.2% -6.9% -3.4% -2.7% -3.7% -2.9% -2.2% -2.24%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 1.00 0.99 0.98 0.94 0.93 0.95 0.97 0.92 0.91 0.93 0.99 0.90 0.87 0.90 0.93 0.91 0.88 0.86 0.78 0.779
Earnings Stability 0.94 0.01 0.01 0.02 0.30 0.00 0.00 0.00 0.20 0.01 0.01 0.00 0.09 0.00 0.00 0.06 0.18 0.36 0.45 0.57 0.570
Margin Stability 0.93 0.95 0.96 0.94 0.94 0.95 0.95 0.93 0.92 0.90 0.89 0.88 0.90 0.90 0.90 0.92 0.92 0.91 0.91 0.89 0.887
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.00 0.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.92 0.87 0.50 0.50 0.84 0.93 0.89 0.84 0.50 0.50 0.50 0.50 0.96 0.955
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.48 0.32 0.29 0.24 0.15 0.20 0.19 0.19 0.09 -0.21 -0.20 -0.13 0.01 0.02 0.07 0.16 0.18 0.25 0.27 0.13 0.129
Gross Margin Trend 0.09 0.06 0.04 -0.03 -0.04 -0.06 -0.07 -0.09 -0.12 -0.15 -0.15 -0.12 -0.07 -0.04 -0.02 0.00 0.01 0.02 0.03 0.03 0.030
FCF Margin Trend -0.36 0.18 0.20 0.09 0.15 0.23 0.33 0.28 0.25 0.18 0.13 0.21 0.29 0.20 0.25 0.22 0.20 0.26 0.21 0.18 0.179
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.35 0.37 0.43 0.41 0.25 0.20 0.10 0.07 0.12 0.06 0.10 0.03 -0.21 -0.04 -0.36 -0.79 -1.16 -3.12 -5.64 -1.69 -1.692
FCF/OCF 1.61 5.74 3.38 2.77 3.88 4.92 7.38 10.24 4.12 4.21 2.76 4.30 0.64 -1.01 0.78 0.85 0.92 0.96 0.96 0.96 0.956
FCF/Net Income snapshot only -1.616
OCF/EBITDA snapshot only 3.374
CapEx/Revenue 20.9% 20.6% 18.1% 20.7% 23.7% 25.5% 20.2% 18.7% 14.4% 7.9% 7.5% 4.1% 2.2% 2.2% 2.0% 1.6% 1.1% 0.9% 0.9% 0.9% 0.92%
CapEx/Depreciation snapshot only 0.123
Accruals Ratio -0.29 -0.04 -0.05 -0.09 -0.13 -0.13 -0.16 -0.16 -0.20 -0.24 -0.25 -0.24 -0.24 -0.20 -0.23 -0.16 -0.17 -0.18 -0.16 -0.20 -0.201
Sloan Accruals snapshot only -0.033
Cash Flow Adequacy snapshot only 22.497
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.1% -0.1% -0.2% -0.3% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.3% -0.2% -0.6% -0.9% -0.4% -0.4% -0.2% -0.1% -0.1% -0.12%
Total Shareholder Return -0.1% -0.1% -0.2% -0.3% -0.2% -0.2% -0.0% -0.0% -0.0% -0.0% -0.0% -0.3% -0.2% -0.6% -0.9% -0.4% -0.4% -0.2% -0.1% -0.1% -0.12%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.02 1.08 1.06 1.03 1.04 1.02 1.03 1.03 1.02 1.03 1.03 1.03 1.04 1.03 1.02 1.07 1.04 1.09 1.18 1.00 1.003
Interest Burden (EBT/EBIT) 1.00 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 -1.49 -0.41 9.07 9.070
EBIT Margin -0.97 -0.11 -0.17 -0.28 -0.32 -0.31 -0.32 -0.29 -0.37 -0.40 -0.41 -0.37 -0.28 -0.29 -0.25 -0.12 -0.11 0.04 0.07 -0.01 -0.013
Asset Turnover 0.45 0.50 0.51 0.50 0.51 0.50 0.53 0.57 0.61 0.62 0.65 0.66 0.67 0.65 0.68 0.67 0.65 0.66 0.67 0.61 0.614
Equity Multiplier 1.25 1.25 1.26 1.26 1.26 1.26 1.25 1.26 1.28 1.29 1.27 1.26 1.28 1.30 1.28 1.28 1.30 1.30 1.26 1.26 1.257
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-4.11 $-0.52 $-0.79 $-1.25 $-1.47 $-1.45 $-1.51 $-1.48 $-1.90 $-2.15 $-2.21 $-2.00 $-1.51 $-1.50 $-1.28 $-0.68 $-0.61 $-0.34 $-0.18 $-0.58 $-0.58
Book Value/Share $7.22 $7.31 $7.14 $6.90 $6.80 $7.02 $6.94 $6.80 $6.33 $6.25 $6.02 $6.03 $5.99 $5.84 $5.77 $6.21 $6.26 $6.27 $6.35 $6.35 $6.35
Tangible Book/Share $6.94 $7.04 $6.88 $6.65 $6.55 $6.78 $6.70 $6.57 $6.11 $6.07 $5.85 $5.85 $5.82 $5.67 $5.60 $6.06 $5.70 $5.74 $5.85 $5.83 $5.83
Revenue/Share $4.14 $4.38 $4.42 $4.38 $4.41 $4.50 $4.64 $4.87 $5.02 $5.22 $5.24 $5.26 $5.22 $5.02 $5.09 $5.18 $5.11 $5.06 $4.98 $4.75 $4.75
FCF/Share $-2.28 $-1.10 $-1.14 $-1.42 $-1.41 $-1.44 $-1.08 $-1.01 $-0.95 $-0.54 $-0.62 $-0.28 $0.21 $-0.06 $0.36 $0.46 $0.65 $1.02 $0.95 $0.93 $0.93
OCF/Share $-1.42 $-0.19 $-0.34 $-0.51 $-0.36 $-0.29 $-0.15 $-0.10 $-0.23 $-0.13 $-0.22 $-0.06 $0.32 $0.05 $0.46 $0.54 $0.71 $1.07 $1.00 $0.98 $0.98
Cash/Share $5.42 $5.25 $4.77 $4.40 $3.96 $3.75 $3.62 $3.35 $3.03 $3.28 $3.11 $3.17 $3.30 $3.24 $3.48 $3.59 $3.84 $4.12 $4.21 $4.25 $4.25
EBITDA/Share $-3.78 $-0.22 $-0.48 $-0.94 $-1.13 $-1.12 $-1.18 $-1.11 $-1.51 $-1.73 $-1.76 $-1.56 $-1.09 $-1.10 $-0.91 $-0.31 $-0.25 $0.56 $0.73 $0.29 $0.29
Debt/Share $0.72 $0.73 $0.90 $0.87 $0.84 $0.83 $0.88 $0.85 $0.84 $0.80 $0.77 $0.75 $0.71 $0.68 $0.65 $0.70 $1.30 $1.24 $0.63 $0.61 $0.61
Net Debt/Share $-4.69 $-4.52 $-3.88 $-3.53 $-3.12 $-2.92 $-2.74 $-2.50 $-2.20 $-2.47 $-2.34 $-2.42 $-2.59 $-2.56 $-2.83 $-2.90 $-2.54 $-2.88 $-3.57 $-3.64 $-3.64
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 13.745
Altman Z-Prime snapshot only 24.194
Piotroski F-Score 4 4 4 3 3 2 3 3 3 2 3 4 6 7 7 6 3 4 6 5 5
Beneish M-Score -2.79 -2.05 -2.45 -2.55 -3.06 -2.93 -3.10 -2.88 -3.17 -3.54 -3.68 -3.79 -3.91 -3.74 -3.97 -3.01 -2.40 -2.66 -2.36 -2.96 -2.959
Ohlson O-Score snapshot only -10.038
ROIC (Greenblatt) snapshot only -1.00%
Net-Net WC snapshot only $3.62
EVA snapshot only $-105054260.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A-
Credit Score 59.35 60.99 61.93 63.91 64.09 65.50 64.75 65.05 65.45 65.69 65.06 65.43 72.98 58.96 51.26 67.53 60.41 93.11 96.86 69.77 69.768
Credit Grade snapshot only 7
Credit Trend snapshot only 2.243
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 72
Sector Credit Rank snapshot only 64

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms